CombinedX AB (publ)
F:K13
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CombinedX AB (publ)
F:K13
|
SE |
|
E
|
Energy SpA
MIL:ENY
|
IT |
|
T
|
Tencent Holdings Ltd
XHAM:NNND
|
CN |
|
Q linea AB
STO:QLINEA
|
SE |
|
E
|
Espey MFG and Electronics Corp
AMEX:ESP
|
US |
|
B
|
Bristol-Myers Squibb Co
XETRA:BRM
|
US |
|
P
|
Persimmon PLC
DUS:OHP
|
UK |
|
A
|
Air Products and Chemicals Inc
LSE:0HBH
|
US |
|
J
|
Jones Lang LaSalle Inc
LSE:0JPB
|
US |
|
M
|
Microchip Technology Inc
XHAM:MCP
|
US |
|
C
|
China Molybdenum Co Ltd
XBER:D7N
|
CN |
|
F
|
First Majestic Silver Corp
XMUN:FMV
|
CA |
|
GomSpace Group AB
LSE:0GE8
|
SE |
|
L
|
Life Science REIT PLC
LSE:LABS
|
UK |
|
Gold Fields Ltd
OTC:GFIOF
|
ZA |
|
Roche Holding AG
OTC:RHHVF
|
CH |
|
China Southern Airlines Co Ltd
OTC:CHKIF
|
CN |
|
N
|
NiSource Inc
DUS:NOU
|
US |
|
Commerzbank AG
XETRA:CBK
|
DE |
|
Tinc Comm VA
LSE:0R7T
|
BE |
|
G
|
Grupo Aeroportuario del Centro Norte SAB de CV
SWB:G7A
|
MX |
|
Trane Technologies PLC
NYSE:TT
|
IE |
|
C
|
Colgate-Palmolive Co
SWB:CPA
|
US |
|
Harmony Gold Mining Company Ltd
OTC:HGMCF
|
ZA |
Balance Sheet
Balance Sheet Decomposition
CombinedX AB (publ)
CombinedX AB (publ)
Balance Sheet
CombinedX AB (publ)
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
30
|
71
|
108
|
121
|
117
|
133
|
104
|
|
| Cash Equivalents |
30
|
71
|
108
|
121
|
117
|
133
|
104
|
|
| Total Receivables |
86
|
107
|
114
|
149
|
162
|
152
|
148
|
|
| Accounts Receivables |
75
|
99
|
106
|
143
|
150
|
145
|
136
|
|
| Other Receivables |
11
|
8
|
9
|
5
|
12
|
6
|
12
|
|
| Inventory |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
|
| Other Current Assets |
10
|
9
|
11
|
14
|
14
|
16
|
18
|
|
| Total Current Assets |
125
|
187
|
234
|
283
|
296
|
300
|
270
|
|
| PP&E Net |
29
|
42
|
27
|
52
|
51
|
79
|
69
|
|
| Intangible Assets |
30
|
65
|
57
|
84
|
84
|
98
|
140
|
|
| Goodwill |
84
|
106
|
105
|
169
|
194
|
257
|
391
|
|
| Note Receivable |
0
|
2
|
1
|
1
|
0
|
0
|
1
|
|
| Long-Term Investments |
2
|
2
|
3
|
7
|
8
|
8
|
8
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Assets |
84
|
106
|
105
|
169
|
194
|
257
|
391
|
|
| Total Assets |
271
N/A
|
407
+50%
|
428
+5%
|
597
+40%
|
633
+6%
|
742
+17%
|
880
+19%
|
|
| Liabilities | ||||||||
| Accounts Payable |
18
|
18
|
31
|
42
|
26
|
32
|
28
|
|
| Accrued Liabilities |
49
|
72
|
66
|
74
|
76
|
98
|
109
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
48
|
57
|
27
|
33
|
33
|
41
|
79
|
|
| Other Current Liabilities |
19
|
30
|
33
|
46
|
57
|
50
|
48
|
|
| Total Current Liabilities |
134
|
177
|
157
|
195
|
191
|
221
|
263
|
|
| Long-Term Debt |
27
|
50
|
29
|
61
|
44
|
65
|
73
|
|
| Deferred Income Tax |
7
|
19
|
15
|
20
|
20
|
18
|
26
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
4
|
2
|
14
|
40
|
|
| Total Liabilities |
168
N/A
|
247
+47%
|
201
-19%
|
279
+39%
|
257
-8%
|
318
+24%
|
401
+26%
|
|
| Equity | ||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
30
|
20
|
46
|
57
|
110
|
128
|
131
|
|
| Additional Paid In Capital |
72
|
139
|
180
|
260
|
265
|
295
|
346
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
425
|
479
|
|
| Total Equity |
102
N/A
|
160
+56%
|
227
+42%
|
318
+40%
|
376
+18%
|
424
+13%
|
479
+13%
|
|
| Total Liabilities & Equity |
271
N/A
|
407
+50%
|
428
+5%
|
597
+40%
|
633
+6%
|
742
+17%
|
880
+19%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
17
|
17
|
17
|
17
|
17
|
18
|
19
|
|